Expert veterinary care for every stage of your pet’s life.
Emergency: 617-522-7282
Poison Control: 888-426-4435
Bringing pets and people together.
Advocate for animals, volunteer, or get help for your pet with our compassionate community services.
Introduction
Computed Tomography (CT) has become a mainstay in veterinary medicine. With the now pervasiveness of this diagnostic tool, it has become vital to make certain distinctions between the various CT protocols. Routine CT scans include a pre-contrast scan, followed by the administration of a contrast medium and a post-contrast scan. These scans are performed to optimize contrast enhancement of the organ parenchyma. Compare this to CT angiography (CTA), which includes a pre-contrast scan followed by post-contrast scans that are timed to achieve specific vascular phases (i.e., arterial, portal, venous, and delayed). CTA is the recommended imaging technique to diagnose various vascular abnormalities, characterize various vascular parenchymal lesions, as well as evaluate tumors, as discussed below.
CTA for Portosystemic Shunts/Portal Vascular Diseases
One of the most common indications for CTA is the evaluation of portosystemic shunts (PSS). Congenital intrahepatic PSS occurs more frequently in large-breed dogs, while congenital extrahepatic PSS is more common in small-breed dogs. It is recommended to further classify either type of shunting prior to surgical intervention (Fig.1). CTA has been shown to be the best modality for characterizing the origin and termination of the shunting vessel, as well as evaluating for possible additional shunting vessels that can be missed on ultrasonography or intraoperative mesenteric portovenography.1 Other portal vascular diseases that can be evaluated on CTA include arterioportal fistulas, acquired portosystemic shunting, and portal vein thrombosis, which can mimic portal hypertension secondary to liver disease. CTA is the modality of choice for portal vein disease with improved detection compared to ultrasound (Fig. 2).2
Figure 1a: Example of an intrahepatic portosystemic shunt. Red arrow denotes the shunting vessel. Figure 1b: The blue star marks the caudal vena cava and the yellow star marks the portal vein.
Other Vascular Anomalies
Other vascular anomalies that are evaluated with CTA include vascular ring anomalies, coronary artery evaluation, arteriovenous fistulas, and thromboembolism, including pulmonary thromboembolism. Vascular ring anomalies are often present in young patients with regurgitation and focal esophageal enlargement cranial to the heart base. There are various types of vascular ring anomalies, including persistent right aortic arch, aberrant subclavian arteries, and double aortic arch, and they can all present with similar clinical signs. CTA will allow for classification of the type of vascular ring anomaly and surgical planning (Fig. 3). Treatment for pulmonary valve stenosis is balloon valvuloplasty; however, the presence of certain coronary artery anomalies is a contraindication for this treatment and can increase the risk of sudden death during the procedure. CTA of the thorax is required for those breeds with a higher risk of this anomaly to map the coronary artery anatomy prior to the valvuloplasty procedure.3 Evaluation of the arterial phase is required to diagnose an arteriovenous fistula. Thus, a routine CT is not sufficient to diagnose this anomaly. A CTA scan is needed to diagnose thromboemboli, especially in the thorax, where the vasculature cannot be evaluated on ultrasound.
Insulinomas
CTA is also the preferred diagnostic test for evaluating insulinomas. Insulinomas are often small and can be difficult to detect on abdominal ultrasound, especially in large or deep-chested dogs, where the entire pancreas is a baseline difficult to image. It has been documented that insulinomas exhibit increased contrast uptake on the arterial phase on CTA, and then most become similarly contrast enhancing to the pancreas parenchyma on the delayed post contrast phase (Fig. 4).4,5 This imaging characteristic makes it difficult to detect small tumors on routine CT, with CTA being a required diagnostic test for insulinomas. In addition, during the arterial phase, marked contrast-enhancing lesions within the liver and lymph nodes can strongly indicate regional metastasis.5
Tumor Evaluation and Surgical Planning
Lastly, CTA has been used for surgical planning of tumor resection and possibly for evaluating certain tumor types. Using preoperative CTA for isolated hepatic masses has allowed for a more accurate diagnosis of the location within the liver, as well as vascular and multilobar involvement, which can better predict surgical difficulty and resectability. Ultrasonography has been shown to correctly localize solitary hepatic masses in only about 50% of cases.6 The most common malignant hepatic tumor type in dogs is hepatocellular carcinoma, which is often described as a large mass with central cyst-like or necrotic regions on CT, compared to nodular hyperplasia, which is smaller and has a more homogeneous appearance post contrast. On CTA, hepatocellular carcinomas tend to exhibit heterogeneous contrast enhancement with irregular central or marginal contrast enhancement in the arterial phase (Fig. 5). In addition, hepatocellular carcinomas tend to be more hypoattenuating compared to the liver parenchyma on the more delayed phases.7 Nodular hyperplasia, on the other hand, tend to exhibit more homogeneous hyperattenuation or isoattenuation compared to the liver parenchyma and other primary hepatic masses on the various post contrast phases, and hepatic metastatic lesions more commonly are homogeneously hypoattenuating in the earlier post contrast phases.8 Despite these imaging characteristics helping to prioritize malignant versus benign lesions, other reports document more of an overlap between tumor types, and ultimately, histopathology remains the gold standard for diagnosis.9
References